Kulkarni, Meghana M.

Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints

Koyama, S., Akbay, E. A., Li, Y. Y., Herter-Sprie, G. S., Buczkowski, K. A., Richards, W. G., Gandhi, L., Redig, A. J., Rodig, S. J., Asahina, H., et al. (2016) · Nature Communications

Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology

Cited by 1,580

Transcriptional enhancers: Intelligent enhanceosomes or flexible billboards?

Arnosti, D. N., & Kulkarni, M. M. (2005) · Journal of Cellular Biochemistry

Genomics and Chromatin DynamicsChromatin Remodeling and Cancer

Cited by 309

Information display by transcriptional enhancers

Kulkarni, M. M., & Arnosti, D. N. (2003) · Development

Genomics and Chromatin DynamicsDevelopmental Biology and Gene Regulation

Cited by 118

A high-throughput immune-oncology screen identifies EGFR inhibitors as potent enhancers of antigen-specific cytotoxic T-lymphocyte tumor cell killing

Lizotte, P. H., Hong, R.-L., Luster, T. A., Cavanaugh, M. E., Taus, L. J., Wang, S., Dhaneshwar, A., Mayman, N., Yang, A., Kulkarni, M., et al. (2018) · Cancer Immunology Research

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 88